- 1、本文档共36页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
FDAManagingPharmaceuticalQualityRiskorUncertaintyManagement
Managing Pharmaceutical Quality: Risk or Uncertainty Management? Ajaz S. Hussain, Ph.D. Office of Pharmaceutical Science CDER, FDA PQRI Workshop February 1, 2005 What is Quality? What is pharmaceutical quality? consistent delivery of the label performance and lack of contamination. operationalzed via a set of pre-specified quality attributes (e.g., specifications, limits) and through the CGMP regulations. FDA, in its quality definition, is standing in for the customer—and it is apparent that health care practitioners and patients highly value an additional drug attribute: product availability Good pharmaceutical quality represents an acceptably low risk of failing to achieve the desired clinical attributes. Management Goals Improving quality and ensuring availability Optimal use of our resources A systems approach to CMC review and CGMP investigations Based on knowledge and process understanding Achieving “quality by design” Demonstrating “science of design” Continuous learning and improvement through “manufacturing science” An Approach for Quality – Risk Connection Concept of Quality by Design (QbD) Product and process performance characteristics are scientifically designed to meet specific objectives, not merely empirically derived from performance of test batches Characteristics important to desired performance must be derived from a combination of prior knowledge and experimental assessment during product development. From this knowledge and data, a multivariate model linking product and process measurements and desired attributes may be constructed. Clinical study would then be viewed as confirmatory performance testing of the model. A Systems Approach Quality can not be tested into a product; it has to be by design Risk/Benefit and Quality Managing Pharmaceutical Quality Quality of a new molecular entity (a potential drug) Intrinsic pharmacological toxicological attributes Identity Complexity A range of uncertainty with respect to identity of “active m
文档评论(0)